Literature DB >> 17021682

Role of SPECT/CT in the preoperative assessment of hyperparathyroid patients.

A Serra1, P Bolasco, L Satta, A Nicolosi, A Uccheddu, M Piga.   

Abstract

PURPOSE: Our purpose was to assess the clinical value and additional benefit of fusion single-photon computed tomography (SPECT) and computed tomography (CT) images in locating the parathyroids in a selected group of patients affected by primary (PHP) and secondary hyperparathyroidism (SHP).
MATERIALS AND METHODS: Sixteen patients (11 women and five men; age range 35-80 years) with severe hyperparathyroidism (HP) (ten PHP, six SHP) were studied by ultrasound (US), and, after i.v. injection of 370 MBq of 99mTc-sestamibi, by planar parathyroid scintigraphy, SPECT and SPECT/CT using a dual-detector scintillation camera GE Infinia Hawkeye. All patients underwent parathyroidectomy.
RESULTS: US findings were inconclusive in 12/16 patients affected by multinodular goitre, and two probable eutopic parathyroid glands were identified. "Double phase" parathyroid scintigraphy identified 14 probable parathyroid glands, SPECT 23 (14 ectopic and nine eutopic) and SPECT/CT confirmed all 23 probable parathyroid lesions, offering more precise localisation and an evident improvement in diagnostic accuracy. Sixteen of these foci of increased uptake were hyperplastic parathyroid glands, six were adenomas, one was a parathyroid carcinoma and one was a thyroid follicular carcinoma. Surgical detection of the 23 sestamibi-positive lesions was correctly matched with 100% of SPECT/CT images and 61% of SPECT data alone. Hybrid imaging thus provided additional data in 39% of lesions, and in three patients with retrotracheal glands, it modified the surgical approach.
CONCLUSIONS: We believe 99mTc-sestamibi SPECT/CT to be a more reliable presurgical method to study a patient subgroup affected by PHP or SHP in whom conventional US and other scintigraphic methods have failed for intrinsic reasons due to the concomitant presence of multinodular goitre or ectopic parathyroid gland. The additional practical benefit derived from this methodology was evident. In fact, anatomical information provided by CT enables precise localisation of the functional abnormalities highlighted by SPECT, and both are essential to a correct surgical approach.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17021682     DOI: 10.1007/s11547-006-0098-0

Source DB:  PubMed          Journal:  Radiol Med        ISSN: 0033-8362            Impact factor:   3.469


  7 in total

1.  Endocrine radionuclide scintigraphy with fusion single photon emission computed tomography/computed tomography.

Authors:  Ka-Kit Wong; Arpit Gandhi; Benjamin L Viglianti; Lorraine M Fig; Domenico Rubello; Milton D Gross
Journal:  World J Radiol       Date:  2016-06-28

Review 2.  A review on the clinical uses of SPECT/CT.

Authors:  Giuliano Mariani; Laura Bruselli; Torsten Kuwert; Edmund E Kim; Albert Flotats; Ora Israel; Maurizio Dondi; Naoyuki Watanabe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-02-25       Impact factor: 9.236

3.  Primary hyperparathyroidism: can ultrasonography be the only preoperative diagnostic procedure?

Authors:  S Tresoldi; G Pompili; R Maiolino; N Flor; L De Pasquale; A Bastagli; F Sardanelli; G Cornalba
Journal:  Radiol Med       Date:  2009-09-22       Impact factor: 3.469

4.  CT-MIBI-SPECT image fusion predicts multiglandular disease in hyperparathyroidism.

Authors:  Gerd Wimmer; Christoph Profanter; Peter Kovacs; Michael Sieb; Michael Gabriel; Daniel Putzer; Reto Bale; Raimund Margreiter; Rupert Prommegger
Journal:  Langenbecks Arch Surg       Date:  2009-08-25       Impact factor: 3.445

5.  Comparison of five parathyroid scintigraphic protocols.

Authors:  Virpi Tunninen; Pekka Varjo; Jukka Schildt; Aapo Ahonen; Tomi Kauppinen; Irina Lisinen; Anu Holm; Hannu Eskola; Marko Seppänen
Journal:  Int J Mol Imaging       Date:  2013-01-21

6.  Role of SPECT and SPECT/CT in the Surgical Treatment of Primary Hyperparathyroidism.

Authors:  Michele L Taubman; Melanie Goldfarb; John I Lew
Journal:  Int J Mol Imaging       Date:  2011-06-21

7.  99m-Technetium Sestamibi Uptake in a Gastric Schwannoma.

Authors:  Mohamed Shawgi; Tamir Ali; Matthew Scott; George Petrides
Journal:  World J Nucl Med       Date:  2018 Jan-Mar
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.